Columbus, OH

Summary: Researchers collaborated to conduct a comprehensive study on multiple myeloma at the molecular level, identifying early detection methods for aggressive tumors based on changes in genetic material affecting protein profiles. Takeaways:. Heterogeneous Disease Progression: Multiple myeloma exhibits diverse progression rates and aggressiveness among patients, complicating treatment predictions and outcomes.

Multiple Myeloma: Mass Spectrometry Aids Early Detection

In part 2 of our interview with Suzanne Lentzsch, MD, PhD, Columbia University's College of Physicians and Surgeon, she touches on potential new therapies, important clinical considerations, and treatment challenge for relapsed/refractory multiple myeloma. In part 1 of an interview, Suzanne Lentzsch, MD, PhD, director of the multiple myeloma and...

Advancements and Challenges in Treating Relapsed/Refractory Multiple Myeloma

Houston, TX

Researchers from the University of Houston identified CD8-fit T cells with high motility and serial killing abilities, potentially enhancing T-cell cancer therapies. The study used the TIMING approach and RNA sequencing, revealing molecular signatures that predict positive patient outcomes. A group of cancer researchers from the University of Houston has...

Cancer Breakthrough: Scientists Discover Game-Changing New Type of T Cells

The CARTITUDE-4 study that found that treatment with cilta-cel led to a statistically significant and clinically meaningful improvement in overall survival among patients with relapsed and lenalidomide-refractory multiple myeloma who received 1 to 3 prior lines of therapy. Findings from the phase 3 CARTITUDE-4 study (NCT04181827) showed that treatment with...

New Hope for Multiple Myeloma: Cilta-Cel Improves Overall Survival

Factors such as age, sex, and family history can impact a person’s risk of getting pancreatic cancer. It is more likely to occur later in life. Certain conditions can also increase the likelihood of pancreatic cancer. Pancreatic cancer develops in the tissues of the pancreas. This organ secretes digestive...

Who is most likely to get pancreatic cancer?

SurvivorNet

The U.S. President of Hematology at Johnson & Johnson understands the plight of multiple myeloma patients and the never-ending worry of relapse. So, he helps lead a team of experts focused on treatments to improve patient's overall quality of life.

Fighting For Multiple Myeloma Patients in Desperate Need: The Commitment From Johnson & Johnson’s Blood Cancer Leader

Newark, NJ

Contributors represent independent, third-party users who have joined our contributor program and self-verified their accounts. They have also demonstrated their experience writing hard news for other outlets. Contributors are expected, like all users, to adhere to our Community Standards.

contributor

Morristown Minute

NEWARK, N.J. – Eight individuals associated with the "793 Bloods" street gang, a subset of the national Bloods gang, have been charged for their roles in a Newark-based drug trafficking organization, U.S. Attorney Philip R. Sellinger announced.

Eight '793 Bloods' Gang Members Charged in Newark Drug Network

Ali Carney, 46, of Newark, received a 65-month prison sentence for conspiring to distribute narcotics, including fentanyl and heroin, and possessing with intent to distribute fentanyl, according to U.S. Attorney Philip R. Sellinger.

Gang Member Sentenced to 65 Months for Drug Trafficking

Cancer Health

Since his diagnosis with incurable Stage IV brain cancer in 2023, Australian doctor Richard Scolyer revealed that he has been cancer-free for a year after undergoing a world-first treatment based on his own research on immunotherapy to treat melanoma, a type of skin cancer, according to BBC. Last year, following...

Doctor Is Cancer-Free Following World-First Treatment He Developed

A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology intervention. ABSTRACT. Objectives: Chronic kidney disease (CKD) is a widely prevalent disease with heterogeneous disease progression. Prior study findings suggest...

Identifying Chronic Kidney Disease Stage 3 With Excess Disease Burden

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer. Non-Hodgkin’s lymphoma (NHL) is a cancer of the lymph nodes. These are small structures in the neck, armpits,...

What is the role of PET scans in non-Hodgkin’s lymphoma?

Oregon State University researchers have discovered compounds that convert a protein known for protecting cancer cells into a tumor killer. Scientists say their findings, several years in the making, open the door to promising therapies for breast cancer and other malignancies whose cells rely on the Bcl-2 protein to evade treatment and develop drug resistance.

Compounds Discovered That Convert a Protein Into a “Tumor Killer”

In the realm of lymphoma and chronic lymphocytic leukemia (CLL), and of the treatments that address them, a global survey of nearly 7000 patients proves there’s a long way to go to eliminate cancer-related fatigue from their lives. Cancer-related fatigue (CRF) unfortunately remains an unmet need: prevalent, underreported, poorly...

Tired of It: Cancer-Related Fatigue in Lymphoma, CLL

Multiple Sclerosis (MS) is a complex condition that affects millions worldwide, yet remains shrouded in mystery for many. This neurological disorder targets the central nervous system, leading to a range of symptoms that can vary wildly from person to person. Understanding MS is crucial, not just for those diagnosed but for everyone, as it fosters empathy and awareness. In this blog post, we'll unveil 12 key facts about MS, shedding light on its causes, symptoms, and impact on daily life. Whether you're newly diagnosed, a supportive friend or family member, or simply curious, these insights aim to demystify MS and provide a clearer picture of what living with this condition entails.

12 Facts About Multiple Sclerosis

CBS Boston

BOSTON - There currently is no cure for Parkinson's disease, but scientists may have discovered a potential path to slow or stop the disease.Parkinson's disease is a brain disorder that can cause movement problems such as tremors, poor balance, and walking difficulties, and it can also impair cognitive function.  There is no cure and treatments aim to simply reduce symptoms. But a new study in mice by researchers at Johns Hopkins offers new hope.  They found that the interaction of two proteins is key to the buildup of protein clumps in the brain that damage healthy brain cells in Parkinson's. They also suggest that disrupting these proteins with a drug already approved by the FDA to treat cancer could potentially slow or stop the brain damage associated with Parkinson's.  The next step would be to conduct clinical trials in humans, but that will take time.  


Drug used for cancer treatment could help slow or stop Parkinson's, study says

Health

Medically reviewed by Gagandeep Brar, MDMedically reviewed by Gagandeep Brar, MDLung cancer is a type of cancer that grows in your lung tissue. Stages of cancer span from 0-4, with stage 4 being the most advanced stage of lung cancer. Lung cancer is often diagnosed in the later stages because symptoms may be difficult to detect before stage 3 or 4. There are two main types of lung cancer—small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).Small cell lung cancer (SCLC) makes up about 10-15% of all lung cancer cases, and non-small cell lung cancer (NSCLC) makes up...

Stage 4 Lung Cancer

Cancer arises when changes in genes that normally control cell division lead to unchecked growth at the expense of healthy tissues. One of the most common genetic alterations across human cancers—occurring in 95% of pancreatic cancers but also many non-small cell lung cancers, colorectal cancers, and others—is in a gene known as KRAS. While promising new treatments targeting KRAS to shrink cancerous tumors have recently gained approval, less than 40% of pancreatic cancers respond to treatment with KRAS inhibitors for reasons that aren’t well understood.

Molecular Portrait of Key Driver of Pancreatic Cancer Offers Hope for Continued Treatment Advances

Tattoos may be a risk factor for malignant lymphoma, according to a study out of Lund University in Sweden. But experts say much more research is required to substantiate such a claim, according to CNN. Published in eClinicalMedicine, the study was conducted by researchers seeking to identify the long-term health...

Are Tattoos a Risk Factor for Lymphoma?

Thyroid cancer might sound scary, but understanding it can make a big difference. Thyroid cancer starts in the thyroid gland, a small butterfly-shaped organ in the neck. This gland controls how your body uses energy, so it's pretty important! Did you know that thyroid cancer is more common in women than men? Also, most cases are found early and treated successfully. There are different types, like papillary, follicular, medullary, and anaplastic, each with its own characteristics. Curious about symptoms? They can include a lump in the neck, trouble swallowing, or changes in your voice. Let's dive into 20 fascinating facts about thyroid cancer to help you understand it better.

20 Best Facts About Thyroid Cancer

Oncologists use biopsy and imaging techniques to diagnose and monitor tumor diseases and assess treatment success. UZH and USZ researchers have now further developed an advanced method to analyze liquid biopsies of DNA fragments in the blood. It is fast and practical, without putting much of a strain on patients. This could make it possible to provide diagnostics and treatments that are more closely tailored to individual patients in the future.

New Blood Test Method Promises Personalized Cancer Treatments

NewsBreak

Study Sheds Light on Early Development of Multiple Myeloma

Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients...

Study Sheds Light on Early Development of Multiple Myeloma

Comments / 0